Health workers’ perceptions and challenges in implementing meningococcal serogroup a conjugate vaccine in the routine childhood immunization schedule in Burkina Faso
作者: Sylvain F. NkwenkeuMohamed F. JallohJenny A. WalldorfRobert L. ZomaFelix TarbangdoSoukeynatou FallSansan HienRoland CombassereCesaire KyLudovic KambouAlpha Oumar DialloAkshaya KrishnaswamyFlavien H. AkéCynthia HatcherJaymin C. PatelIsaïe MedahRyan T. NovakTerri B. HydeHeidi M. SoetersImran Mirza
作者单位: 1UNICEF Ouagadougou, 01 PO Box 3420, Ouagadougou 01, Burkina Faso
2U.S. Centers for Disease Control and Prevention, 30329, Atlanta, GA, USA
3Institut National de Statistique et Démographie, Ouagadougou, Burkina Faso
4Davycas International, Ouagadougou, Burkina Faso
5Ministère de la Santé, Ouagadougou, Burkina Faso
6UNICEF, 10017, New York, NY, USA
刊名: BMC Public Health, 2020, Vol.20 (Suppl 1), pp.1378-1388
来源数据库: Springer Nature Journal
DOI: 10.1186/s12889-020-8347-z
关键词: Meningococcal vaccineMeasles vaccineVaccine introductionHealth workersBurkina FasoVaccination barriersPerceptionsChallengesVaccination demandEffective vaccine administrationVaccination coverage improvementSecond year of lifeCo-administration
英文摘要: Abstract(#br)Background(#br)Meningococcal serogroup A conjugate vaccine (MACV) was introduced in 2017 into the routine childhood immunization schedule (at 15–18 months of age) in Burkina Faso to help reduce meningococcal meningitis burden. MACV was scheduled to be co-administered with the second dose of measles-containing vaccine (MCV2), a vaccine already in the national schedule. One year following the introduction of MACV, an assessment was conducted to qualitatively examine health workers’ perceptions of MACV introduction, identify barriers to uptake, and explore opportunities to improve coverage. Methods(#br)Twelve in-depth interviews were conducted with different cadres of health workers in four purposively selected districts in Burkina Faso. Districts were selected to include urban...
全文获取路径: Springer Nature  (合作)
影响因子:2.076 (2012)